Kovatchev, Boris
Article History
First Online: 22 December 2017
Competing interests
: B.K. has received speaking engagements/honoraria from Dexcom and Sanofi; research support managed by the University of Virginia from Ascensia Diabetes Care, Dexcom, Roche Diagnostics and Tandem Diabetes Care; patent royalties managed by the University of Virginia from Johnson & Johnson and Sanofi; and is shareholder/board member of TypeZero Technologies, Inc.